View in EDS

Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply.

Saved in:
Bibliographic Details
Title: Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply.
Authors: Freeman TP; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath BA2 7AY, UK; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: t.p.freeman@bath.ac.uk., Hindocha C; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK., Baio G; Department of Statistical Science, University College London, London, UK., Curran HV; Clinical Psychopharmacology Unit, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK.
Source: The lancet. Psychiatry [Lancet Psychiatry] 2020 Oct; Vol. 7 (10), pp. 840.
Publication Type: Letter; Comment
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101638123 Publication Model: Print Cited Medium: Internet ISSN: 2215-0374 (Electronic) Linking ISSN: 22150366 NLM ISO Abbreviation: Lancet Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32949514
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Freeman+TP%22">Freeman TP</searchLink>; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath BA2 7AY, UK; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: t.p.freeman@bath.ac.uk.<br /><searchLink fieldCode="AU" term="%22Hindocha+C%22">Hindocha C</searchLink>; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK.<br /><searchLink fieldCode="AU" term="%22Baio+G%22">Baio G</searchLink>; Department of Statistical Science, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Curran+HV%22">Curran HV</searchLink>; Clinical Psychopharmacology Unit, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101638123%22">The lancet. Psychiatry</searchLink> [Lancet Psychiatry] 2020 Oct; Vol. 7 (10), pp. 840.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101638123 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2215-0374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222150366%22">22150366 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Psychiatry <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32949514
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2215-0366(20)30376-X
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 840
    Titles:
      – TitleFull: Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Freeman TP
      – PersonEntity:
          Name:
            NameFull: Hindocha C
      – PersonEntity:
          Name:
            NameFull: Baio G
      – PersonEntity:
          Name:
            NameFull: Curran HV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2020 Oct
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2215-0374
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: The lancet. Psychiatry
              Type: main
ResultId 1